Arrowhead Receives Orphan Drug Designation for ARC-AAT
Go back to Arrowhead Receives Orphan Drug Designation for ARC-AAT| ARROWHEAD RESEARCH (NASDAQ: ARWR) | Delayed: 68.79 +2.31 (3.47%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $66.48 | 52 Week High | $8.22 | |||
| Open | $67.46 | 52 Week Low | $3.07 | |||
| Day High | $69.26 | P/E | N/A | |||
| Day Low | $66.06 | EPS | $-1.30 | |||
| Volume | 2,347,934 | |||||
